How have GOSS and INCR total returns compared?

Over the past 5 years, GOSS delivered -59.51% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.

Gossamer Bio, Inc. (GOSS) vs InterCure Ltd. (INCR)

A side-by-side comparison of Gossamer Bio, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GOSS

Gossamer Bio, Inc.

$66M

$10.87HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT

INCR

InterCure Ltd.

$63M

$5.33HealthcareDelayed quote: Oct 6, 2026, 11:20 AM EDT

Total return — GOSS vs INCR

growth of $100 · dividends reinvested · last 8y

GOSS -99.3% (-45.8%/yr)INCR -72.8% (-15.0%/yr)INCR compounded faster over this window

Log scale — wide-divergence pair

GOSS INCR

GOSS vs INCR: by the numbers

•GOSS is the larger company ($66M vs $63M market cap).
•Both run net losses; INCR's is the smaller (-13.72% vs -235.00% net margin).

Metrics side by side

Valuation

Metric	GOSS	INCR
P/S ratio	1.25	0.79
P/B ratio	N/A	0.51
FCF yield	N/A	11.64%

Profitability

Metric	GOSS	INCR
Gross margin	99.56%	14.40%
Operating margin	-336.81%	2.49%
Net margin	-235.00%	-13.72%
ROE	N/A	-8.80%
ROIC	N/A	-4.72%

Growth (annualized)

Metric	GOSS	INCR
Revenue CAGR (5Y)	N/A	32.71%
Total return CAGR (5Y)	-59.51%	-30.85%

Frequently asked

How have GOSS and INCR total returns compared?: Over the past 5 years, GOSS delivered -59.51% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GOSS analysis Full INCR analysis Interactive comparison tool

Dig into the metrics

Gossamer Bio ROE InterCure ROE Gossamer Bio operating margin InterCure operating margin Gossamer Bio revenue growth InterCure revenue growth Gossamer Bio free cash flow InterCure free cash flow

Gossamer Bio & InterCure appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.